Point Counterpoint: Risk Stratification for Biopsy - Biomarkers

10 Views
Published
Juan Javier-DesLoges, MD, MS, UC San Diego School of Medicine, San Diego, California, focuses on contemporary advancements in prostate cancer detection, emphasizing the integration of biomarkers and MRI for biopsy decision-making. In this 5-minute presentation, he emphasizes the evolving landscape of prostate cancer diagnostics, driven by innovative tests and collaborative approaches to patient care.
Category
Oncology
Be the first to comment